| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
3,318.05
|
|
Change (%)
|
68.20 (2.10%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
3,262.95
-
3,352.05
|
|
52-Week Range (RS)
|
3,202.70
-
6,717.50
|
|
Beta (1 Year)
|
0.42
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Board of Sanofi India recommends final dividend |
| Sanofi India standalone net profit declines 32.42% in the December 2025 quarter |
| Sanofi India to hold board meeting |
| Sanofi India Ltd - Sanofi India Limited - Record Date |
| Sanofi India Ltd - Sanofi India Limited - Copy of Newspaper Publication |
| Board of Sanofi India recommends Interim Dividend |
| Sanofi India standalone net profit declines 7.54% in the September 2025 quarter |
| Board of Sanofi India approves change in directorate |
| Sanofi India Ltd - Sanofi India Limited - Press Release |
| Sanofi India Ltd - Sanofi India Limited - Cessation |
|
|
|
| Incoporation Year : 1956 |
| Chairman : Aditya Narayan |
| Ownership Group : MNC Asc-Hoechst |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Sanofi India Ltd Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai, Mumbai, Maharashtra-400072 |
Phone:91-22-28032000 Fax:91-22-28032939 |
| E-Mail : igrc.sil@sanofi.com |
| URL : http://www.sanofiindialtd.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
18-Mar-2026 |
3462.55 |
-4.17 |
| 1Month |
25-Feb-2026 |
4138.75 |
-19.83 |
| 3Month |
26-Dec-2025 |
4093.00 |
-18.93 |
| 6Month |
25-Sep-2025 |
4882.05 |
-32.04 |
| 1Year |
25-Mar-2025 |
6094.50 |
-45.56 |
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Contra Fund |
0.20 |
99.75 |
| Aditya Birla SL Large Cap Fund |
0.33 |
99.27 |
| Nippon India Pharma Fund |
1.10 |
91.31 |
| Nippon India Growth Mid Cap Fund |
0.20 |
89.92 |
| Nippon India Small Cap Fund |
0.13 |
84.85 |
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
26,397.35 |
-1.59 |
35,921.55 |
25,350.00 |
56,094.37 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,321.60 |
0.59 |
3,515.95 |
2,220.00 |
39,329.30 |
| Pfizer Ltd |
4,703.15 |
0.82 |
5,987.65 |
3,742.90 |
21,515.84 |
| Astrazeneca Pharma India Ltd |
8,415.50 |
1.52 |
10,653.05 |
6,501.60 |
21,038.75 |
| Sanofi Consumer Healthcare India Ltd |
4,214.95 |
1.32 |
5,954.00 |
3,950.50 |
9,707.29 |
|
|
|
|